OxySure (OXYS) Welcomes Tom Cox to its Board of Directors
Frisco, Texas, April 13, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today welcomed Thomas J. Cox to its Board of Directors.
 |
Tom Cox is an advisor and consultant to various public companies and private equity firms. Prior to that, Tom was Executive Vice President with MSC Industrial Supply, a NYSE listed global company for 17 years until his retirement in November 2014. In that role his areas of responsibility included Field Sales, Call Centers, Ecommerce, Telesales, National Accounts /Government and he oversaw an organization of approximately 3,000 Associates. He has extensive experience in sales force effectiveness and acquisitions/integration. During Tom’s tenure, MSC Industrial's sales increased from just over $500 million to close to $3 billion in sales. Before joining MSC, Tom was President of his own transportation business, MailNet, with offices in the United States and overseas. He also spent a decade in the United States and Europe with TNT Express Worldwide, an international transportation company. At TNT, he was responsible for Worldwide Sales and Marketing based in Europe and also held the position of President of the Americas. |
Mr. Cox holds a bachelor's degree in Accounting from St. John's University.
“We are very pleased to have Tom join our Board,” said Julian Ross, Chairman & CEO of OxySure. “Tom’s deep experience in developing global sales, as well as in business development and mergers & acquisitions will be invaluable to our Company as we grow to the next level.”
“I am very excited to join the OxySure Board,” commented Tom Cox. “I have known Julian Ross for several years and I look forward to working closely with him in building OxySure into a large profitable company.”
Tom Cox replaces Vicki Jones who resigned from the OxySure Board due to work load constraints.
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Forward-Looking Statements
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013.
Investor Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989
Redchip Companies, Inc.
Jon Cunningham: jon@redchip.com
800-733-2447, ext. 107
Tags: